[Acute leukemia developing in the second trimester of pregnancy].


Journal

[Rinsho ketsueki] The Japanese journal of clinical hematology
ISSN: 0485-1439
Titre abrégé: Rinsho Ketsueki
Pays: Japan
ID NLM: 2984782R

Informations de publication

Date de publication:
2020
Historique:
entrez: 10 9 2020
pubmed: 11 9 2020
medline: 21 10 2020
Statut: ppublish

Résumé

Acute leukemia (AL) during pregnancy poses a substantial risk to both mothers and fetuses. Treatment for leukemia should be initiated promptly; however, the management of AL in pregnant women and fetuses is usually challenging, especially during the second trimester. Here, we report two cases of AL that developed during the second trimester of pregnancy. In one case, chemotherapy was initiated while continuing the pregnancy; in the second case, a cesarean section was performed prior to chemotherapy initiation. As per current medical records, both infants are thriving without any medical problems. The optimal strategy for the treatment of AL during pregnancy typically includes chemotherapy after delivery. However, if fetal development is not sufficient for ex utero survival, the only alternatives available are the initiation of treatment while continuing the pregnancy or treatment after therapeutic abortion (if it is legally allowed). According to previous studies and as per the results from our first case, the initiation of chemotherapy while sustaining the pregnancy may be an acceptable option if it is conducted with appropriate informed consent. The treatment of AL in the second trimester of pregnancy should be carefully decided, while taking into account the medical, legal, and social aspects, such as gestational weeks, maternal and fetal status, and wishes of the patients and their families.

Identifiants

pubmed: 32908047
doi: 10.11406/rinketsu.61.865
doi:

Types de publication

Case Reports Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

865-869

Auteurs

Yuichi Horigome (Y)

Department of Hematology, Kitasato University School of Medicine.

Noriyuki Tadera (N)

Department of Hematology, Kitasato University School of Medicine.

Yusuke Michishita (Y)

Department of Hematology, Kitasato University School of Medicine.

Tomomi Motohashi (T)

Department of Hematology, Kitasato University School of Medicine.

Takashi Ishida (T)

Department of Hematology, Kitasato University School of Medicine.
Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine.

Sosei Okina (S)

Department of Hematology, Kitasato University School of Medicine.

Hirotoshi Kamata (H)

Department of Hematology, Kitasato University School of Medicine.

Koji Miyazaki (K)

Department of Transfusion and Cell Transplantation, Kitasato University School of Medicine.

Takahiro Suzuki (T)

Department of Hematology, Kitasato University School of Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH